View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
September 29, 2020

US FDA clears Masimo’s handheld pulse oximetry device

The US Food and Drug Administration (FDA) has cleared Masimo’s handheld pulse oximetry device called Rad-G Pulse Oximeter.

The US Food and Drug Administration (FDA) has cleared Masimo’s handheld pulse oximetry device called Rad-G Pulse Oximeter.

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

The rugged handheld device delivers clinically proven SET pulse oximetry, respiration rate from the pleth (RRp) and other key parameters for spot-checking and continuous monitoring.

It features a rechargeable battery, rubber casing, and a lightweight and convenient new direct-connect sensor that can be used for monitoring both adults and children.

The company said that clinicians will be able to quickly assess patients and make informed care decisions anywhere, using the pulse oximetry or vital signs checking provided by the Rad-G Pulse Oximeter.

The device can be used in a range of settings, including physicians’ offices, outpatient services, long-term care facilities, wellness clinics, first-response scenarios, and limited-resource environments.

Masimo founder and CEO Joe Kiani said: “With the Rad-G Pulse Oximeter, we set out to create an accessible, high-quality care solution that clinicians can rely on in a multitude of care settings. We are bringing our expertise in pulse oximetry to a smaller, more lightweight, rugged and versatile handheld device without sacrificing any of the advantages that help provide clinicians with critical insights into patient status.

“As the Covid-19 pandemic continues, it’s more imperative than ever that caregivers have access to the most accurate and reliable pulse oximetry monitoring technologies. We are proud to offer Rad-G among our suite of solutions powered by the breakthrough technology, SET pulse oximetry.”

Rad-G is compatible with Masimo’s portfolio of reusable and single-patient-use sensors. It is expected to provide clinicians with the ability to customise the solution based on the unique requirements of each care setting.

The company developed its first spot-check device in partnership with The Bill & Melinda Gates Foundation.

Last month, the FDA approved Masimo’s Pleth variability index (PVi) as a continuous, noninvasive, dynamic indicator of fluid responsiveness in select populations of mechanically ventilated adult patients.

Related Companies

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network